What happens when you take fluoxetine with St. John's wort?
Fluoxetine is one of the original SSRIs, marketed as Prozac and available generically. It blocks the serotonin transporter so that more serotonin remains in the synaptic cleft, prolonging its signaling. St. John's wort (Hypericum perforatum) is a botanical product whose constituents - hyperforin chiefly - also inhibit serotonin reuptake. When both compounds are present, the combined inhibition of reuptake can lead to a dramatic rise in synaptic serotonin levels. This sets the stage for serotonin syndrome, a potentially life-threatening cluster of agitation, confusion, fever, sweating, tachycardia, hypertension, tremor, clonus, and hyperreflexia.
Fluoxetine is distinctive among SSRIs because of its pharmacokinetics. The parent drug has a half-life of around 1-4 days, but its active metabolite norfluoxetine has a half-life of 7-15 days. After stopping fluoxetine, meaningful drug levels can persist for four to six weeks. That means the serotonergic interaction with St. John's wort is not over the day someone stops fluoxetine - it continues for more than a month.
Layered on top of the serotonin issue, St. John's wort induces cytochrome P450 enzymes (CYP3A4, CYP2C19, CYP2C9) and P-glycoprotein. Fluoxetine itself is a CYP2D6 inhibitor and is metabolized by CYP2D6 and CYP3A4. Sustained St. John's wort use can therefore lower fluoxetine and norfluoxetine plasma levels enough to risk loss of antidepressant efficacy - while simultaneously raising serotonergic tone via direct pharmacodynamic interaction. The combination is unpredictable in both directions.
Why is this important?
Serotonin syndrome can develop quickly, sometimes within hours of an interacting dose. Mild cases mimic flu or anxiety: jittery, sweaty, tachycardic, a little confused. Moderate cases add clonus (rhythmic muscle jerks especially in the ankles), hyperreflexia, fever, and dilated pupils. Severe cases progress to rigidity, hyperthermia above 40 degrees C, seizures, metabolic acidosis, and rhabdomyolysis with risk of acute kidney injury and death. There is no antidote, only supportive care and, in some cases, the serotonin antagonist cyproheptadine.
St. John's wort is sold over the counter and marketed as a gentle, natural mood support. Patients on fluoxetine may try it during a low mood episode without realizing they are stacking two serotonergic agents. Pharmacists and clinicians often miss it on intake forms because patients do not count herbal products as "medications." The U.S. National Center for Complementary and Integrative Health (NCCIH) explicitly warns that combining St. John's wort with antidepressants can cause a potentially life-threatening rise in serotonin.
The long fluoxetine half-life is also clinically important when switching antidepressants or considering St. John's wort after discontinuation. Stopping fluoxetine on Monday and starting St. John's wort on Tuesday is not a washout - it is a co-administration of two serotonergic agents with substantial overlap for weeks.
What should you do?
If you take fluoxetine, do not start St. John's wort. If you are currently taking both, contact your prescriber promptly. Do not stop fluoxetine on your own - abrupt discontinuation can cause discontinuation symptoms and a brief paradoxical worsening of mood, and the serotonin syndrome risk from the supplement persists for weeks even after the supplement is stopped. Seek emergency care if you have a fast heart rate, fever, severe agitation, muscle stiffness, or twitching.
If you and your prescriber plan to transition from fluoxetine to St. John's wort (which most psychiatrists would not recommend in favor of a different prescription option), the conventional washout is 5 weeks off fluoxetine before introducing another serotonergic agent. This matches the FDA-recommended washout for switching fluoxetine to an MAO inhibitor.
Disclose every supplement to your healthcare team. Read multi-ingredient supplement labels carefully - St. John's wort is often hidden in "mood," "calm," "emotional support," or "sleep" blends and is sometimes labeled only by Latin name (Hypericum perforatum) or regional name (Johanniskraut, millepertuis).
Which specific products are affected?
This warning applies to all forms of fluoxetine, including Prozac, Prozac Weekly, Sarafem (for premenstrual dysphoric disorder), Symbyax (fluoxetine plus olanzapine), and authorized generics. Liquid and capsule formulations carry the same risk. On the supplement side, the warning covers all Hypericum perforatum products: standardized extracts (typically 0.3% hypericin or 3-5% hyperforin), capsules, tablets, tinctures, teas, and topical preparations if taken internally. Combination products marketed for stress, sleep, or mood may contain St. John's wort.
Other serotonergic agents to be aware of include tramadol, triptans (sumatriptan family), MDMA, dextromethorphan, MAO inhibitors (including linezolid and methylene blue), other SSRIs and SNRIs, and tryptophan/5-HTP. Any of these stacked on top of fluoxetine plus St. John's wort raises serotonin syndrome risk further.
The bottom line
Fluoxetine and St. John's wort should not be combined. The fluoxetine plus St. John's wort interaction is particularly tricky because fluoxetine's active metabolite norfluoxetine persists for weeks, extending the interaction window well beyond the day someone stops the drug. Treat St. John's wort as off-limits while on fluoxetine, and discuss a proper washout with your prescriber before any switch.